A*STAR Infectious Diseases Labs (A*STAR IDL)
Deconstructing the esophagus cell by cell
3 Mar 2025Researchers uncovered how specialised stem cells act as building blocks for the esophagus, shaping its development and offering insights into treating related diseases.
Immune crosstalk fuels viral flames
5 Feb 2025A*STAR researchers find that ordinary communications between immune cells during chikungunya virus infection can drive joint inflammation seen in the disease.
Pathways to Impact
30 Dec 2024Through its focus on attracting, developing and retaining talents in science and technology, A*STAR is helping to build a rich national ecosystem of research, innovation and enterprise.
Reinforcing frontline defences against variants
14 Nov 2024Antibodies in mucous membranes may be key in protecting against SARS-CoV-2 variants, pointing to the need for COVID-19 vaccines that target these antibody responses.
Virus killers get under the skin
10 May 2024Research suggests monitoring individuals previously infected with Zika virus for chronic skin diseases caused by overactive T cells.
Mixed shots hit a moving target
19 Jan 2024While the new Omicron XBB COVID-19 subvariant deftly dodges immune defences even in vaccinated individuals, researchers find that mixed mRNA vaccines may offer a vital boost of protection.
Shielding seniors from a crowned killer
8 Dec 2023A study reveals how age, SARS-CoV-2 variants and booster shots affect immune responses to the COVID-19 vaccine.
What’s behind the rise of mpox?
12 Jul 2023Scientists survey how the mpox virus spreads through populations, the immunology of infections and current treatment interventions.
Spotting the mechanisms of COVID-19 organ damage
4 Jul 2023A novel tissue-profiling approach provides new insights into the mechanisms of fatal COVID-19 by analysing
different molecules and cell populations within organs.
Putting vaccine booster alternatives to the test
24 May 2023Inactivated COVID-19 vaccines could be an equally potent alternative for people with allergic sensitivities to mRNA-based vaccines.
Mixing boosters strengthen vaccine protection
24 Apr 2023An analysis of cellular immune responses reveals that mixing COVID-19 vaccines and boosters may offer enhanced protection for at-risk populations.
Molecules to medicine
19 Apr 2023Leveraging on its public sector and industry collaborations, A*STAR and the Experimental Drug Development Centre hold the keys to effective drug discovery and development.